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Abstract
Saccharomyces cerevisiae has been a key experimental organism for the study of infectious
diseases, including dsRNA viruses, ssRNA viruses and prions. Studies of the mechanisms of virus
and prion replication, virus structure and structure of the amyloid filaments that are the basis of
yeast prions have been at the forefront of such studies in these classes of infectious entities. Yeast
has been particularly useful in defining the interactions of the infectious elements with cellular
components: chromosomally encoded proteins necessary for or blocking the propagation of the
viruses and prions, and proteins involved in expression of viral components. Here we emphasize
the L-A dsRNA virus and its killer-toxin-encoding satellites, the 20S and 23S ssRNA naked
viruses, and the several infectious proteins (prions) of yeast.
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I. Introduction
Here we review the viruses and prions of Saccharomyces cerevisiae, including the dsRNA
viruses that resemble the cores of mammalian dsRNA viruses, the 'naked RNA' single-
stranded RNA viruses that are closest in sequence to some RNA bacteriophage, and the
yeast prions that are self-propagating amyloids of various chromosomally encoded proteins.
These infectious elements of yeast share a mode of transmission by cell-cell mating; none
are known to include an extracellular phase. The dsRNA and ssRNA viruses lack the outer
virion layer typical of the corresponding viruses of other organisms that use an extracellular
route as the primary mode of transmission. The retrotransposons of yeast, Ty1, Ty2,.., Ty5,
(not reviewed here, but see: Maxwell and Curcio 2007; Beauregard et al. 2008) likewise
resemble the cores of retroviruses, with no env gene and no extracellular phase, but with a
similar intracellular life cycle.
Biologically, the yeast viruses resemble other virus groups that do not have a known
extracellular phase. The Endornaviruses (Fukuhara et al. 2006; Roossinck et al. 2011) are
large (~14 kb) dsRNA unencapsidated replicons in plants and fungi. Partitiviruses are
encapsidated dsRNA viruses of plants and fungi, also without an extracellular phase
(Ghabrial et al. 2005). An array of Hypoviruses, moderating the pathogenicity of
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Cryphonectria parasitica for Chestnut trees, are strictly intracellular RNA viruses (Nuss
2005). Moreover, endogenous retroviruses and some Herpesviruses are unable to spread via
a cell-free intermediate.
II. L-A virus and the killer satellite dsRNAs
L-A, as the type species of Totiviridae, is a 4.6 kb single-segment dsRNA virus with a
icosahedral coat comprised of a single major coat protein (called Gag, for reasons that will
be evident), and a Gag-Pol fusion protein formed by ribosomal frameshifting and including
the RNA-dependent RNA polymerase. L-A is stably maintained in cells, without apparent
slowing of growth, but its presence in only 15 of 70 wild S. cerevisiae (Nakayashiki et al.
2005) indicates it must have a net detrimental effect.
Several satellite dsRNAs are found in some strains, called M1, M2, M28 or Mlus, each
encoding a secreted protein toxin and immunity to the toxin (Schmitt and Breinig 2006). M
dsRNAs encode a preprotoxin which is processed by cleavage to produce the mature toxin.
Preprotoxin ORFs are not related with host-encoded genes, with the exception of klus
prepotoxin, which shows a high degree of conservation with S. cerevisiae YFR020W ORF,
of unknown function, suggesting an evolutionary relationship (Rodriguez-Cousino et al.
2011)
These toxins kill other cells by different mechanisms. Among them, K1 and K28 have been
studied in detail. They interact with sensitive cells through receptors in the cell wall or the
plasma membrane. Ionophoric K1 disrupt cytoplasmic membrane function by forming
cation-selective ion channels (Martinac et al. 1990). K28 toxin, in contrast, blocks DNA
synthesis and arrests cells in early S phase of the cell cycle (Schmitt et al. 1996).
A. Virion structure—The X-ray structure of the L-A virus (Naitow et al. 2002; Tang et al.
2005) shows an icosahedral structure with 'T=2' symmetry, a supposedly forbidden mode
(Fig. 1a). In fact, the structure is a T=1 structure (sixty units) with an assymetric dimer of
Gag as the unit (Esteban and Wickner 1986; Caston et al. 1997; Naitow et al. 2002). The
dsRNA is packed in layers inside the virion, and pores at the 5-fold axes allow access of
nucleotides to the interior for RNA synthesis and the escape of the new viral (+) strands to
the cytoplasm. A groove in the virion surface includes residue His154, the site of attachment
of 7mGMP removed from cellular mRNAs (Fig. 1b; see below).
B. L-A and M encoded proteins—L-A has two long ORFs, called Gag and Pol for their
analogy with retroviruses (Fig. 2). The 5' Gag ORF encodes the major coat protein and Pol,
overlapping with the 3' end of the Gag ORF, encodes the RNA dependent RNA polymerase,
expressed only as a fusion protein with Gag. Virus particles contain only 1-2 copies of Gag-
Pol, made by a -1 ribosomal frameshift similar in mechanism to that of many retroviruses
(Dinman et al. 1991).
M dsRNA encodes a preprotoxin which is processed by cleavage after dibasic residues by
Kex2p followed by removal of the dibasic residues by Kex1p (Leibowitz and Wickner 1976;
Bostian et al. 1983; Julius et al. 1984; Cooper and Bussey 1989) (Fig. 2). This processing
pattern was immediately recognized to resemble that of precursors of insulin and several
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other human hormones, and led to the discovery of the corresponding (homologous)
processing enzymes (Steiner et al. 1992).
C. The replication cycle—The L-A virus replicates entirely inside the coat. New (+)
strands are made inside the coat from the dsRNA template by a conservative mechanism and
are extruded from the particles where they are translated and/or encapsidated to form new
particles (Fig. 3). Newly encapsidated (+) strands are converted to dsRNA form within the
particles to complete the cycle. Note that the (+) and (-) strands are made at different points
of the replication cycle.
Examination of virus particles carrying a deletion mutant of L-A (called X) and of the M1
satellite dsRNA suggested a 'head-full replication' model, in which a single (+) strand is
encapsidated, and it replicates within the virion until the particle is full of dsRNA (Esteban
and Wickner 1986; Esteban and Wickner 1988) (Fig. 3). Then new (+) strands are extruded
from the particles. Indeed, M1 particles with a single dsRNA molecule often retain newly
made (+) strands, while those with two M1 dsRNA molecules per particle export all of their
new (+) strand transcripts (Esteban and Wickner 1986). Moreover, it has been directly
shown that a single (+) strand is initially encapsidated (Fujimura et al. 1990).
D. Transcription—The (+) strand synthesis process goes on inside the particles and is a
conservative reaction, meaning parental strands stay together (Herring and Bevan 1974;
Fujimura et al. 1986). Detailed studies of the transcription, replication and packaging of the
L-A virus employed an in vitro system in which the enzymes were supplied by empty
particles, produced by exposure of virions to low salt conditions (Fujimura and Wickner
1988). These opened empty particles specifically bind viral (+) ssRNA in a reaction whose
specificity was shown to be the same as the packaging reaction (see below), can convert
these (+) strands to dsRNA form (the replication reaction, see below) and can transcribe
these dsRNA molecules or dsRNA added initially to the particles.
E. Translation. Ribosomal frameshifting—The 5' Gag and 3' Pol open reading frames
overlap by 130 nt. Most ribosomes translating Gag terminate at the Gag termination codon,
but about 1% of ribosomes translating Gag perform a -1 ribosomal frameshift at a special
sequence into the Pol open reading frame and synthesize a Gag-Pol fusion protein (Fujimura
and Wickner 1988; Icho and Wickner 1989; Dinman et al. 1991). The frameshift signal
consists of a 'slippery site' whose sequence is ...G GGU UUA GG... with the Gag reading
frame indicated, and a pseudoknot just 3' to this slippery site. The pseudoknot makes the
ribosomes pause with the underlined codons in the ribosomal A and P sites. The slippery site
is such that pairing of the non-wobble bases is still correct if the ribosome shifts back one
base. This happens to about 1% of the ribosomes, and when they resume translation in the
new frame, they extend the polypeptide to make the Gag-Pol fusion protein (Dinman et al.
1991). This mechanism serves to a) encode two proteins from one RNA segment,
conserving space, b) fixes the ratio of Gag to Gag-Pol proteins by adjusting the structure of
the frameshift site, a ratio which is critical for the efficient propagation of the virus (Dinman
and Wickner 1992), c) strongly suggests that the Pol domain is properly incorporated on the
inside of the viral particle when the Gag domain is incorporated into the particles [note that
the C-terminus of the Gag domain faces the inside of the particles (Naitow et al. 2002)].
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F. 60S ribosomal subunits and SKI2, SKI3, etc—Mutants in any of a wide array of
genes that are partially deficient in 60S subunits result in loss of M dsRNA and decreased
copy number of L-A dsRNA (e.g. Ohtake and Wickner 1995; Edskes et al. 1998). Because
the viral mRNAs lack a 3' polyA, and polyA may have a special role in the 60S subunit
joining step (Munroe and Jacobson 1990; Searfoss et al. 2001; Kahvejian et al. 2005),
mutants deficient in 60S subunits may tip the balance of translation away from the viral
transcripts and toward the cellular mRNAs (Edskes et al. 1998).
The SKI (superkiller) genes (Toh-e et al. 1978; Ridley et al. 1984; Benard et al. 1998)
include SKI1/XRN1, a 5' exoribonuclease specific for uncapped RNAs with a prominent role
in mRNA degradation (Larimer et al. 1992), while SKI4 and SKI6 are subunits of the
'exosome' complex, originally named because it was believed to be composed of
exoribonucleases (Mitchell et al. 1997), but now known to be devoid of such activities
(Chlebowski et al. 2011). SKI2, SKI3 and SKI8, encode a cytoplasmic complex (Brown et al.
2000). SKI2, 3, 6, 7 and 8 together block the expression of nonpolyA mRNAs, as judged by
electroporation experiments (Masison et al. 1995; Benard et al. 1998; Benard et al. 1999).
While all are involved in the 3' exonuclease degradation of mRNA (Jacobs-Anderson and
Parker 1998), kinetic experiments suggest that translation effects may also be involved.
SLH1 is a paralog of SKI2, and the ski2 slh1 double mutant expresses Cap+ poly(A)-
mRNAs with the same kinetics as it does Cap+ polyA+ mRNAs (Searfoss and Wickner
2000). This result indicates that the translation apparatus does not inherently need polyA.
G. N-acetylation of Gag is needed for viral assembly—MAK3, MAK10 and MAK31
are each necessary for L-A and M propagation, and together form an N-acetyltransferase
complex with Mak3p the catalytic subunit (Sommer and Wickner 1982; Toh-e and Sahashi
1985; Tercero and Wickner 1992; Rigaut et al. 1999). Mak3p recognizes the four N-terminal
residues of L-A Gag, and acetylates the initiator methionine, a modification necessary for
viral assembly (Tercero et al. 1992; Tercero and Wickner 1992; Tercero et al. 1993).
Homologs of the Mak3-Mak10-Mak31 N-acetyltransferase complex are now known in
many organisms including a human complex (e.g., (Starheim et al. 2009)).
H. L-A cap-snatching—The prominent feature of eukaryotic mRNA is the presence of
the cap structure (m7GpppX-) at the 5’ end. The structure is crucial for the efficient
translation and stability of mRNA. In the cell and for most viruses the cap is installed on
mRNA co-transcriptionally by three enzymatic reactions (Venkatesan et al. 1980; Shuman
1995). RNA triphosphatase eliminates the 5’ γ phosphate from a nascent PolII transcript.
Guanylyltransferase forms a Gp-enzyme intermediate with GTP and transfers Gp to the
diphosphorylated 5’ end of the transcript to form a 5’-5’ triphosphate linkage. Finally,
methyltransferase methylates the guanine base at N7. Influenza virus installs its mRNA with
a cap structure in a non-conventional mechanism (cap snatching) (Plotch et al. 1981; Boivin
et al. 2010). The trimeric viral polymerase binds to the cap structure of host mRNA, cleaves
the RNA endonucleolytically 10-13 nt downstream and utilizes the capped fragment as a
primer to transcribe the viral genome. Recently, L-A virus has been found to furnish its
transcript with a cap structure by a novel cap-snatching mechanism (Fujimura and Esteban
2011). L-A only transfers the m7Gp moiety from host mRNA to the diphosphorylated 5’ end
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of the viral transcript. Furthermore, unlike influenza virus, L-A utilizes Gag to catalyze the
reaction.
In 1992, Sonenberg and coworkers found that Gag of L-A virus covalently binds to the cap
structure of mRNA (Blanc et al. 1992). Subsequent studies showed that m7Gp derived from
mRNA decapping is attached covalently to His-154 of Gag (Blanc et al. 1994). Gag with a
mutation at His-154, when expressed from a vector, could support replication of M1,
interestingly however, its expression (killer toxin production) was severely affected by the
mutation (Blanc et al. 1994). L-A and M1 transcripts have diphosphate at their 5’ ends
(Fujimura and Esteban 2010). Isolated L-A virions can transfer the m7Gp moiety from
mRNA to the 5’ end of the L-A transcript, thus forming the authentic cap structure found in
the yeast (Fig. 4) (Fujimura and Esteban 2011). The α and β phosphates at the 5’ end of the
transcripts are conserved in the triphosphate linkage of the product. A mutation at His-154
abolished the cap transfer reaction. Because the toxin production is severely affected by the
mutation, it indicates that capping is essential for the efficient expression of the viral
transcript. The N7 methylation of the 5’ terminal G is essential for cap donor activity, and
the smallest molecule with donor activity is the dinucleotide cap analog m7GpppG
(Fujimura and Esteban 2012). The cap acceptor needs to be 5’ diphosphorylated. A 5’ tri- or
monophosphorylated viral transcript does not function as cap acceptor. Although L-A
virions can utilize exogenously added viral transcripts as cap acceptors, the capping reaction
requires the viral polymerase actively engaging in transcription (Fujimura and Esteban
2012). Because the polymerase is confined inside the virion, whereas the cap-snatching site
is located on the cytoplasmic surface of the virion (see below), it indicates coordination
between the transcription and cap-snatching sites. This coordination may minimize the risk
of accidental capping of non-viral RNA when the polymerase is dormant. The physical
separation of the cap-snatching site from the transcription site may ensure that not all of
transcripts are capped. This will allow the virus to synthesize two types of transcripts: one,
non-capped transcripts presumably destined for encapsidation (genomic ssRNA) and the
other, capped transcripts for translation (mRNA).
Structural studies of L-A virions have revealed a trench on the outer surface of Gag that
includes His-154 (Naitow et al. 2002; Tang et al. 2005). The trenches are located in the Gag
asymmetric dimmer close to the icosahedral 2-and 3-fold symmetric axes. L-A transcripts
are made inside the virion and presumably released to the cytoplasm through one of the
pores located at the 5-fold axes (Naitow et al. 2002). His-154 is located at the tip of a loop
(residues 144-163) that is part of the upper rim of the trench. Upon m7GDP binding, the rim
moves inwardly and forms a closed conformation (Tang et al. 2005). Guanylyltransferase
also contains a trench that can adopt either open or closed conformation during the mRNA
capping reaction (Hakansson et al. 1997; Chu et al. 2011). Furthermore, secondary structure
elements around the trench of Gag resemble those of guanylyltransferase (Naitow et al.
2002). The latter enzyme forms a Gp-enzyme intermediate with GTP and transfers Gp to the
diphosphorylated 5’ terminus of PolII transcript. Thus the capping reaction of L-A
resembles that of guanylyltransferase. These similarities suggest a convergent evolution.
In the trench, Tyr-150, Asp-152, Tyr-452 and Tyr-538 are located close to the bound
m7GDP, suggesting their involvement in cap recognition. Mutagenesis analyses indicate that
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these residues are crucial for decapping activity (Tang et al. 2005). The eminent feature of
cap binding proteins is the presence of two aromatic amino acids in their cap-binding
pockets (Hakansson et al. 1997; Chu et al. 2011). The aromatic rings of these amino acids
sandwiched the m7G aromatic ring of the cap structure by stacking. The delocalization of the
positive charge arising from the N7 methylation of the guanine contributes to strong
interactions between the πelectrons of the stacked aromatic rings (Hu et al. 1999). Tyr-452
and Tyr-538 of L-A Gag sandwich m7GDP by a potential stacking (Tang et al. 2005).
Furthermore, the cap-snatching reaction requires N7 methylation of the cap for donor
activity (Fujimura and Esteban 2012). It is likely that L-A virus utilizes a mechanism similar
to those of cap binding proteins to recognize mRNA for cap snatching. Fungal totiviruses
(members of the genus Totivirus), including L-BC, share the same (or similar) four amino
acids aforesaid as well as His-154 at comparable positions in their capsid proteins (Fujimura
and Esteban 2011). Gag of LBC has been observed to possess decapping activity (Blanc et
al. 1992). Therefore, it is likely that the cap-snatching mechanism of L-A is widespread
among totiviruses of fungi.
I. Encapsidation—Viral (+) strands, made in the transcription reaction, are extruded from
the particles where they may serve as mRNAs and/or be encapsidated by Gag and Gag-Pol
to make new viral particles. The RNA encapsidation signal is located 400 nt from the 3' end
of the L-A (+) strand and consists of a stem-loop with a critical A residue protruding from
the 5' side of the stem (Esteban et al. 1988; Fujimura et al. 1990). The encapsidation signal
is recognized by the N-proximal part of the Pol part of Gag-Pol, resulting in packaging of a
single (+) strand in each virus particle (Fujimura et al. 1992; Ribas et al. 1994).
J. Replication—The viral (+) strands are converted to dsRNA form by the RNA
dependent RNA polymerase in a reaction involving recognition of an internal site, largely
overlapping with the packaging site, and synthesis beginning at the 3' end of the template
(Esteban et al. 1989). The polymerase apparently binds first to the internal site, and then
begins synthesis at the 3' end, without sliding along the template (Fujimura and Wickner
1992).
III. Biology of the S. cerevisiae dsRNA viruses—L-BC is a 4.6 kb dsRNA virus with
sequence similarity to L-A, but clearly constituting a distinct replicon (Sommer and Wickner
1982; Park et al. 1996). L-BC and L-A replicate stably in the same cells, and while L-A
supports the M dsRNA satellites, L-BC does not. L-A requires MAK3, MAK10 and MAK31,
the N-acetyltransferase encoding genes, but L-BC does not, and the clo1 mutation that
results in loss of L-BC does not affect L-A (Wickner 1980; Wickner and Toh-e 1982;
Wesolowski and Wickner 1984).
Wild isolates of L-A show a variety of genetic activities, defined by their ability to support
the propagation of M dsRNAs, and their interaction with each other (Wickner 1980;
Wickner and Toh-e 1982). Although cDNA clones have been used extensively in defining
the activities of L-A encoded functions, these activities resisted study because it has not yet
been possible to launch the L-A virus from transcripts of the cDNA clone.
Wickner et al. Page 6
Adv Virus Res. Author manuscript; available in PMC 2014 August 22.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Mutants in (at least) ski2, 3, and 8 are cold-sensitive for growth, and actually die at low
temperature if they carry M dsRNA (Ridley et al. 1984). Although if carrying only L-A,
these ski mutants have a great deal more dsRNA than when they also carry M, they are not
cold-sensitive (Ball et al. 1984; Ridley et al. 1984). The molecular basis of this phenotype
has not been found, but it suggests that the presence of the toxin-immunity-encoding M
dsRNAs is not an undiluted advantage. It has recently been shown that S. cerevisiae can
support an RNAi system if only Dicer and Argonaut are imported from S. castetllii
(Drinnenberg et al. 2009), and shown that the M and L-A dsRNAs are lost from the
constructed strains (but not L-BC) (Drinnenberg et al. 2011). However, M dsRNAs are
rather rare in wild strains (Young and Yagiu 1978; Nakayashiki et al. 2005), indicating that
there must be a significant disadvantage resulting from carrying it that more than makes up
for the obvious advantage. This remains an unsolved problem.
IV. Yeast Narnaviruses: 20S and 23S RNAs
Most laboratory strains of S. cerevisiae harbor 20S RNA and fewer strains 23S RNA. These
viruses are small positive-stranded RNA viruses belonging to the family Narnaviridae and
encode only their RNA dependent RNA polymerases. The RNA genomes are not packed
into a massive protein capsid, but form ribonucleoprotein complexes with their cognate
RNA polymerases in the host cytoplasm. 20S RNA was first found in 1971 by Kadowaki
and Halvorson as an RNA species accumulated under sporulation conditions (Kadowaki and
Halvorson 1971). The name was based on its mobility relative to those of 18S and 25S
rRNAs in a gel. Garvik and Haber established that 20S RNA is a cytoplasmically inherited
genetic element (Garvik and Haber 1978) and that the accumulation of 20S RNA is
independent of the sporulation process of the host. In 1984, Wesolowski and Wickner
reported two heat-inducible, cytoplasmically inherited dsRNAs, W and T (Wesolowski and
Wickner 1984). When 20S RNA (Matsumoto and Wickner 1991) and W (Rodriguez et al.
1991) were independently cloned and sequenced, it was evident that they were identical but
in two different molecular forms, ssRNA and dsRNA. Subsequently, T dsRNA was also
characterized by sequencing and its ssRNA form (23S RNA) was identified (Esteban et al.
1992) .
The 20S RNA and 23S RNA genomes are small (2514 and 2891 nt long, respectively)
(Rodriguez-Cousino et al. 1998) and rich in GC. Both RNAs possess 5 nt inverted repeats
(5’ GGGGC...GCCCC-OH) at the 5’ and 3’ termini. Each RNA has a single open reading
frame that spans almost the entire viral genome (Fig. 5A). The 5’ non-translating regions are
only 12 nt in 20S RNA and 6 nt in 23S RNA. 20S RNA and 23S RNA encode 91 kDa (p91)
and 104 kDa proteins (p104), respectively (Matsumoto and Wickner 1991; Rodriguez et al.
1991; Esteban et al. 1992), both with consensus sequences for RNA-dependent RNA
polymerases and most closely related to those of the positive stranded RNA coliphages such
as Qβ.
20S and 23S RNAs migrate in sucrose gradients almost as naked RNAs, and phenol
treatment hardly changes their mobility (Widner et al. 1991; Esteban et al. 1994; Garcia-
Cuellar et al. 1995). The mass of most viruses consists of capsids and lipid layers, indicating
that 20S and 23S RNAs are not encapsidated. However, p91 and p104 are associated with
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20S RNA and 23S RNA, respectively (Esteban et al. 1994; Garcia-Cuellar et al. 1995) in a
1:1 protein:RNA stoichiometry in the host cytoplasm (Solorzano et al. 2000). Preliminary
data indicate that the resting complexes of 20S RNA contain no host proteins. Pull-down
experiments detected no proteins other than p91 in metabolically labeled resting complexes.
Furthermore, p91 can form a resting complex with 20S RNA in E. coli in the absence of
yeast proteins (Vega 2010).
A. Launching systems of narnaviruses—20S and 23S RNA viruses can be generated
from vectors (Esteban and Fujimura 2003; Esteban et al. 2005). In both cases, the complete
sequences of the viral genomes are placed downstream of the constitutive PGK1 promoter
(Fig. 5B). The efficiency of virus launching is high. 20S RNA can be generated in more than
70% of colonies of the yeast transformed with the vector. It is critical to directly fuse the
hepatitis delta virus ribozyme to the 3’ end of the viral genome. In the absence of the
ribozyme the vectors failed to generate the viruses, and insertion of a few Gs between the
viral 3’ end and the ribozyme greatly reduced viral generation. In the latter case, the virus,
once generated, is indistinguishable from the authentic one because the extra Gs at the 3’
end were eliminated during the launching process. The launching vectors also contained
non-viral sequences (about 40 nt) between the major transcription initiation site of the
promoter and the viral 5’ end. These sequences were also eliminated during the launching
process and, as will be discussed later, the Ski1 5’ exonuclease plays the major role in their
elimination.
The narnaviruses have a terminal repair system (Fujimura and Esteban 2004; Esteban et al.
2005). The elimination of the last and penultimate Cs at the viral 3’ end in the vector, or
changing them to the other nucleotides did not affect virus generation. However, the viruses
generated were found to have recovered these terminal Cs. It indicates that these terminal Cs
are essential for replication, but that the presence of a repair system makes them dispensable
for virus launching (Fig. 6A). By contrast, modifications at the 3rd or 4th C from the 3’ end
abolished virus generation. Although the 5th G is part of the 5 nt inverted repeat, this G is
not essential for replication and a modified nucleotide at this position can be retained in the
generated viruses. The terminal repair could be done by host enzymes, or by the viral RNA
polymerase. A modified nucleotide at the 3’ terminus may be removed by an exonuclease
and then the correct nucleotides might be install by the CCA-adding enzyme. The positive
and negative strands of 20S and 23S RNAs contain stem-loop structures adjacent to the 3’
ends, which resemble the so-called top-half domain of tRNA (Fig. 6A). The CCA-adding
enzyme recognizes the top-half domain of tRNA precursors and adds CCA to their 3’ ends
in a non-templated fashion. That 20-30% of the positive and negative strands of W and T
dsRNAs have a non-templated A at the 3’ termini (Rodriguez-Cousino and Esteban 1992) is
consistent with the possible involvement of this enzyme in the repair. Alternatively, the
terminal repair could be done by the viral polymerase during replication. RdRps are also
known to add a non-templated A at the 3’ end of the products. Although 20S RNA and 23S
RNA genomes have 5 nt inverted repeats at both termini, it is unlikely that the 5’
complementary sequence is used as template to correct modifications at the 3’ end because
both a modification at the 3’ end and the compensatory mutation at the 5’ end were
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corrected to the wild type sequences without negative effects on virus generation (Fujimura
and Esteban 2004).
20S RNA can also be generated from the negative strands expressed from a vector (Esteban
et al. 2005). Because p91 can not be decoded from the negative strand, virus generation
required p91 expressed from a second plasmid. Since modifications or deletions at the 3’
terminal or penultimate positions did not affect virus generation, it is likely that the same
repair mechanism observed on the positive strand also operates on the negative strand.
B. Cis-acting signals—In a resting complex p91 interacts with 20S RNA at least at three
different sites, 5’ end, 3’ end and, to a lesser extent, internal sites (Fujimura and Esteban
2007). The 5’ end site is located in the second stem-loop structure from the 5’ end (Fig. 6B).
The stem structure is important for complex formation but the loop sequence is not. It has
been observed that there is a tight correlation between complex formation and virus
generation among those mutants, suggesting that a stable complex formation is a
prerequisite for virus generation. The 3’ end site is located at the very end of the 3’ terminus,
partially overlapping with the 5 nt inverted repeat. The 3rd and 4th Cs from the 3’ end are
important for complex formation but the 3’ terminal and penultimate Cs, as well as the 5th G
were dispensable. Since the 3rd and 4th Cs but not the 5th G were essential for replication,
there is again a good correlation between replication and complex formation at the 3’ end
site. It is not known whether the 3’ end site extends further inside, as in the 23S RNA virus.
The internal site is located in the middle of the 20S RNA molecule between nt 1253 and
1513. Mutations at the 5’ or 3’ end site reduced complex formation to a basal level (10-20%)
compared with the unmodified RNA. However, the effects of these mutations are not
additive, that is, the combination of mutations at these two sites does not reduce complex
formation further down. It suggests that the internal site is responsible for the basal level of
complex formation. Secondary structure prediction reveals intramolecular long distance
interactions among the 5’ end, 3’ end and internal regions, which bring the three sites close
together (Fujimura and Esteban 2007). This may allow a p91 molecule to simultaneously
interact with these three sites in the resting complex.
In the case of the 23S RNA/p104 complex, only the 3’ end site has been analyzed in detail
(Fujimura and Esteban 2004; Fujimura and Esteban 2004). The 3’ end site is bipartite,
consisting of the 3rd and 4th Cs from the 3’ end and a stem-loop structure adjacent to the 3’
end (Fig. 6A). Like 20S RNA, the 5th G from the 3’ end is dispensable for complex
formation and also for virus generation. The stem-loop structure contains a mismatched pair
of purines in the middle of the stem. This mismatch is important for both complex formation
and virus generation. Any combination of purines in the mismatch supported both complex
formation and virus generation, however, eliminating one of the purines or changing them
with pyrimidines abolished both activities. Because 20S RNA has no mismatched pair at the
stem-loop structure adjacent to the 3’ end, this may contribute to the specificity of complex
formation in these viruses.
C. SKI1 anti-viral activity—During virus launching, the 20S RNA and 23S RNA
genomes in the vector are transcribed from the PGK1 promoter by PolII. The transcripts
possess not only non-viral sequences (about 40 nt) from the vector but also the cap structure
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at the 5’ ends (Fig. 5B). The generated viruses, however, have no extra nucleotides at the 5’
ends. These extra nucleotides are eliminated during virus generation. mRNA degradation in
eukaryotes usually begins with the shortening of the poly(A) tail at the 3’ end, followed by
decapping at the 5’ end by the Dcp1/Dcp2 decapping enzyme (Wilusz et al. 2001; Parker
and Song 2004). Because decapping is a crucial step in mRNA degradation, numerous
proteins (Lsm1p-7p, Pat1p, Dhh1p, etc) are involved in this reaction. Then the decapped
RNA is degraded by the SKI1/XRN1 5’ exonuclease. Alternatively, deadenylated RNA is
digested by the 3’ exonuclease exosome (Mitchell et al. 1997; Jacobs-Anderson and Parker
1998). In yeast, the SKI1/XRN1 5’ exonuclease plays a major role in mRNA degradation. It
was found that the launching plasmid failed to generate the 20S RNA virus in ski1Δ or
dhh1Δ strains (Esteban et al. 2008), signifying the importance of the mRNA degradation
pathway in virus launching. When the 5’ non-viral sequence was reduced from 47 to 9 nt,
the plasmid generated the 20S RNA virus in ski1Δ strains indicating that the SKI1 5’
exonuclease is largely responsible for eliminating the long 5’ extra sequence. Interestingly,
these genes did not affect replication of 20S RNA virus when the endogenous virus was
introduced by a cytoplasmic mixing from a donor strain. This confirms that these genes are
involved in the 5’ processing of the transcripts but not in viral replication per se.
Because of the 5’ exonuclease activity, SKI1 is involved in host defense against L-A virus
(Masison et al. 1995). The copy number of L-A increases several-fold in ski1Δ strains and
the virus can be easily cured from the cell by over-expression of the SKI1 gene. By contrast,
endogenous 20S RNA virus is fairly insensitive to overexpression of SKI1 (Esteban et al.
2008). The positive strand of L-A has no prominent structures at its 5’ end, whereas 20S
RNA (and also 23S RNA) has a strong secondary structure at the 5’ end (Fig. 6B).
Furthermore, the first 4 nt at the 5’ ends of both 20S and 23S RNAs are Gs and these
nucleotides are buried at the bottom of the stem. It is known that the progression of the 5’
SKI1 exonuclease is blocked by a cluster of Gs and also by a strong secondary structure. It is
likely that these features confer on 20S RNA insensitivity to the antiviral activity of SKI1.
Indeed, when mutations were introduced to the stem to destabilize the structure, 20S RNA
became vulnerable to SKI1 activity (Esteban et al. 2008). These observations indicate that
SKI1 is a potent weapon for the host to fight against RNA virus infection and suggest that
20S and 23S RNAs have evolved to develop elaborated secondary structures at the 5’ ends,
partly as a countermeasure against SKI1 because the viruses have no protective capsid. The
3rd and 4th Cs from the 3’ ends are not only essential for replication but also important for
resting complex formation in 20S and 23S RNA viruses. It strongly suggests that p91 and
p104 directly interact with these terminal nucleotides of the cognate RNAs. These
interactions may be important to protect the viral genomes from degradation by the
exosome. The copy numbers of 20S and 23S RNAs increase several-fold in ski2, ski3, ski4,
ski7 or ski8 mutants (Matsumoto et al. 1990; Ramirez-Garrastacho and Esteban 2011),
suggesting that the viruses have some stages in their replication cycles vulnerable to the 3’
exosome. This group of Ski proteins also blocks expression specifically of non-polyA
mRNAs (Masison et al. 1995; Benard et al. 1999; Brown and Johnson 2001), a feature
common to L-A, 20S and 23S.
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D. Replication Intermediates—In vegetative growing cells the copy number of 20S
RNA is very low (5-20 copies per cell) (Matsumoto et al. 1990). Under sporulation
conditions (1% K acetate) it reaches up to 20000 copies per cell, predominantly in the form
of resting complexes with the positive strands. Lysates prepared from these cells contain a
minor amount of replication intermediates that possess actinomycin D- and α-ammanitin
insensitive RNA polymerase activity (Garcia-Cuellar et al. 1997). The intermediate consists
of a full-length negative strand template, a positive strand with less than unit length, and p91
(Fujimura et al. 2005). It is not known whether the intermediate also contains host proteins.
The synthesis of RNA results from chain-elongation of the positive strand. The de novo
synthesis of 20S RNA has not been observed in the lysates. Upon completion of RNA
synthesis, the positive strand product and the negative strand template are released from the
intermediate. The released strands can be retained on a negatively-charged membrane,
suggesting that they are still associated with protein. The RNAs in the replication
intermediate have largely a single-stranded RNA backbone. Deproteination with phenol
converts them to a dsRNA form. Therefore, W is not a replication intermediate of 20S RNA
but a byproduct. Fig. 7 shows a model of the replication intermediates of 20S RNA (Esteban
and Fujimura 2006). The initiation process of intermediate formation is not known. The
intermediate may contain two p91 molecules: one interacting with the negative strand at the
3’ and 5’ end regions and the other polymerizing the positive strand and also concurrently
interacting with its 5’ cis site. These interactions may protect both RNAs from degradation
by exonucleases. Furthermore, these interactions may prevent both RNAs from annealing in
a long stretch beyond the polymerization site, thus keeping the RNA backbone largely single
stranded. Because each p91 has distinct interactions with the respective strands in the
intermediate, this may condition their partition when the positive and negative strands are
released. In the cell, the negative strand, as soon as released, may be recruited again to form
a new replication intermediate, because the majority of negative strands are found in the
form of positive strand-synthesizing intermediates.
Although a resting complex of the negative strand as well as a negative strand-synthesizing
intermediate apparently are also constituents of the 20S RNA replication cycle, these
complexes have not been analyzed yet because of their low abundance in the cell.
VI. Yeast Prions
In addition to the nucleic acid-containing viruses, yeast can harbor any of several infectious
proteins or prions, conceptually similar to the mammalian prions (Table 1). Most yeast
prions are based on self-propagating amyloids, although one is a protease that can activate
its own inactive precursor protein (Roberts and Wickner 2003). Amyloid is a linear polymer
of a single protein species, with a largely beta-sheet structure in which the beta strands are
perpendicular to the long axis of the filament. Surprisingly, a single prion protein can be the
basis of any of many different prion variants that differ genetically and biologically. Based
on the in-register parallel beta sheet architecture of several yeast prions, a mechanism has
been proposed for the templating of amyloid conformation that must underlie this stable
inheritance of prion variant.
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A. The range of yeast prions—[URE3] and [PSI+] were the first yeast prions found,
each long known as mysterious non-chromosomal genetic elements assumed to be nucleic
acid based, but not correlated with known RNA or DNA molecules. Based on their genetic
properties, [URE3] and [PSI+] were shown to be prions of Ure2p, a regulator of nitrogen
catabolism, and Sup35, a subunit of the translation termination factor (Wickner 1994). These
prions produce a phenotype similar to that of partial deficiency of the corresponding protein.
[PIN+] is a prion of Rnq1p, a protein of no known function. The [PIN+] phenotype is the
ability to rarely cross-seed other prions, originally [PSI+]. Several other new prions were
discovered based on their ability to produce a Pin-like effect, including [SWI+] (Du et al.
2008), a prion of the chromatin-remodeling factor Swi1p, [OCT+], a prion of the
transcription repressor Cyc8p (Patel et al. 2009), and [MOD+], a prion of the tRNA
isopentenyltransferase Mod5p (Suzuki et al. 2012). Another, [MOT+], a prion of Mot3p,
was found in a general screen of Q/N-rich proteins (Alberti et al. 2009).
B. Most yeast prions are amyloid filaments—Each of the prions listed in Table 1 is
an amyloid of the corresponding protein. Each prion protein has a domain (the prion
domain) which is responsible for the prion properties of the whole protein, and constitutes
the part of the protein that forms amyloid. The Ure2p prion domain changes from
unstructured (Pierce et al. 2005) to beta sheet (Taylor et al. 1999; Baxa et al. 2005), the
remainder of the molecule remaining largely unchanged in structure (Bai et al. 2004). Solid-
state NMR studies combined with electron microscopic data showed that amyloids of the
prion domains of Ure2p, Sup35p and Rnq1p are parallel in-register beta sheets, with the
sheets folded length-wise along the long axis of the filaments (Fig. 8) (Shewmaker et al.
2006; Baxa et al. 2007; Wickner et al. 2008).
C. Prion variants—Remarkably, a single protein, with a single sequence, can be the basis
of several (perhaps many) different prion variants, with different biological properties and
different amyloid conformations. Most variants are quite stably propagated (though some
variants are unstable and are lost or change to another variant). Different prion variants are
due to the same protein sequence adopting (and propagating) different amyloid
conformations (Bessen and Marsh 1994; Tanaka et al. 2004). How does a prion protein
adopt any of several/many different conformations and reliably transmit that conformation
to new molecules joining the ends of the filaments? This has long been the central puzzle of
prions, and because proteins were believed to be unable to template their conformation, it
was argued that prions must have a nucleic acid component, just like other elements of
heredity.
D. In-register parallel architecture of prions can explain heritable
conformation—The parallel in-register architecture greatly restricts the possible
structures. The beta sheet of the prion domain is known, in each case to be folded
lengthwise, but the locations of the folds are not known. It is hypothesized that the folds are
at different locations in different prion variants, and that the resulting different
conformations have different biochemical and biological properties as a result (Wickner et
al. 2007; Wickner et al. 2010) (Fig. 8). Most importantly, this hypothesis provides a means
to explain how a given architecture can be stably propagated and transmitted to new
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molecules joining the end of the filament. The same energetically favorable interactions
between aligned identical amino acid side chains that keep the structure in-register will
direct a newly joining molecule to adopt the same conformation as those already in the
filament, and thus to have its turns (folds) at the same locations (Wickner et al. 2007;
Wickner et al. 2010) (Fig. 8). There is currently no other model to explain prion variant
information propagation. The only prion for which a detailed atomic structure has been
determined, that of HET-s of the filamentous fungus Podospora anserina (Saupe 2011), has
a beta-helix structure (Wasmer et al. 2008), and this prion does not have prion variants.
E. Chaperones and yeast prions—Because protein conformation is such a central
aspect of prions, it has been found that chaperones play several crucial roles in their
generation and propagation. Hsp104, acting with Hsp70s and Hsp40s, is important in prion
replication (Chernoff et al. 1995), breaking long filaments into shorter ones, perhaps by
extracting protein monomers from the middle of the filaments (Paushkin et al. 1996; Ness et
al. 2002; Kryndushkin et al. 2003). All of the known amyloid-based yeast prions require
Hsp104 for their propagation. Overproduction of Hsp104 cures the [PSI+] prion, apparently
by a different, but as yet unknown, mechanism (reviewed by Reidy and Masison 2011), The
cytoplasmic Hsp70s, Ssa1p and Ssa2p, as well as the Hsp40s, Ydj1p and Sis1p, are also
critical for prion propagation (Newnam et al. 1999; Jung et al. 2000; Moriyama et al. 2000;
Sondheimer et al. 2001). Hsp70s are ATPases, whose ATP/ADP states determine the
binding and release of substrates. These states are regulated by the Hsp40s, by nucleotide
exchange factors and other components, with a clear correlation between ATP/ADP state
and prion propagating ability (Sharma and Masison 2009).
F. Transmission barriers: interspecies and intraspecies—Early recognition that
sheep scrapie could be transmitted to goats, but only with difficulty, gave rise to the species
barrier concept, shown to be largely based on differences between donor and recipient in the
prion protein sequence (Prusiner et al. 1990). A similar phenomenon is known in yeast for
[PSI+] (Chen et al. 2007) and for [URE3] (Edskes et al. 2011). Indeed, there are even intra-
species barriers to transmission of [PSI+] between different polymorphs of Sup35p within S.
cerevisiae, suggesting that such barriers have been selected to protect cells from the ill
effects of this prion (Bateman and Wickner 2012). It is notable that the species barriers are
prion variant - dependent, so that with the same donor - recipient pair of prion protein
sequences, transmission may be efficient or near zero, depending on the particular prion
variant/amyloid conformation whose transmission is being tested (Edskes et al. 2009; Chen
et al. 2010).
VII. Biology of yeast prions—Although yeast prions are proposed to benefit their host
(Eaglestone et al. 1999; True and Lindquist 2000), there is as yet no reproducible evidence
for this conclusion (Namy et al. 2008). Prion variants differ dramatically in their properties,
with the usual mild variants of [PSI+] and [URE3] used in laboratory studies showing little
discernible effect on growth, but other, probably more common variants being lethal or
nearly so (McGlinchey et al. 2011). To estimate the overall benefit or detriment of yeast
prions, a survey of 70 wild strains was carried out. Although the 2 micron DNA plasmid,
estimated by two groups to confer a ~1-3% slowing of growth on various strains, was found
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in 38 of 70 wild strains, none of these strains had [URE3] or [PSI+] and only 11 had [PIN+]
(Nakayashiki et al. 2005). This suggests that even the mild variants of each of these prions
confers a net overall detriment of >1% on their hosts.
Other lines of evidence indicate that the [URE3] and [PSI+] prions are detrimental. Cells
infected with either prion show a stress response with induction of Hsp104 and Hsp70s,
indicating that the cells consider prion infection a stress (Jung et al. 2000; Schwimmer and
Masison 2002). The prion domains have non-prion functions, a central role in mRNA
turnover for the Sup35p prion domain and an important role in stabilization of Ure2p for its
prion domain (Hoshino et al. 1999; Hosoda et al. 2003; Shewmaker et al. 2007). Thus, these
domains are not conserved to allow prion formation, but for their normal function. In fact,
prion formation is not conserved. Although a range of species conserve some sequence in
the Ure2p prion domain, several of these are unable to form [URE3] as tested in S.
cerevisiae, but some species that do not show sequence conservation can form the prion
(Edskes et al. 2011; Safadi et al. 2011). Thus, prion formation appears to be a sporadic
condition. Indeed, prion formation occurs stochastically, and often under conditions which
make matters worse for the cell, suggesting that it is not adaptive.
VIII. Prospects
Although a large body of work has accumulated on the yeast viruses and prions, many
interesting problems remain to be solved. Each of these elements are found in a limited array
of wild strains, indicating that they must be a net detriment to the host, probably beyond
simply use of some energy and material resources. Elucidation of the nature of these
interactions would be of broad interest. The M dsRNAs use the coat supplied by L-A, and
several lines of evidence suggests that L-A has first call on its own encoded coat proteins,
but clear proof of this is lacking. The newly elucidated cap – stealing by L-A helps explain
the ability of viral mRNAs to be translated, but they still lack the 3' polyA, a stringent
requirement for translation in eukaryotes. Moreover, the ski1/xrn1 gene was first detected by
its 'superkiller' phenotype (Toh-e et al. 1978), suggesting that cap – stealing by L-A is not
100% efficient. Do Ski2,3,8 affect translation or only 3'->5' decay?
How and why are 20S and 23S amplified under sporulation conditions (10,000x!), the
phenomenon that led to their first detection (Kadowaki and Halvorson 1971). Can the virus-
launching vectors be put to use for biotechnologic purposes? Narnaviruses exist not in the
form of a conventional virion structure with a protective capsid, but as ribonucleoprotein
complexes in the host cytoplasm. A fine structural analysis of these complexes is essential to
understand the unique mode of narnavirus existence. Resting complexes seem to have no
host proteins. But, are there any host proteins directly involved in narnavirus replication?
20S and 23S RNAs have strong secondary structures at the 5’ ends. This leads to the
question of how p91 and p104 are translated, cap-dependent or –independent? In the latter
case, these structures may serve as ribosome entry sites.
While yeast prions seem to have a parallel in-register architecture, the heterogeneity of
amyloids made in vitro has so far precluded detailed structures, so that the hypothesis that
prion variants differ in the locations of the folds in the sheet (see above) has yet to be
verified. Moreover, the basis of the different properties of yeast prions is not yet understood.
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Yeast prions can be lethal (McGlinchey et al. 2011), but the variety of lethal prion variants
and the mechanisms of the pathology they produce are just beginning to be explored. The
fungal prion [Het-s] is so far unique in having demonstrated benefit to the cell (Coustou et
al. 1997), but it also produces a (pathologic) meiotic drive phenomenon (Dalstra et al. 2003),
clouding the issue. Suggestions that yeast prions are beneficial (Eaglestone et al. 1999; True
and Lindquist 2000) have met with an enthusiastic reception not yet justified by the data.
Yeast prions are important models for the increasingly common amyloidoses and promise to
continue to reveal important clues to understanding and dealing with these diseases.
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Fig. 1.
L-A virion structure. a. “T=2” architecture with two non-identical forms of the Gag major
coat protein (A and B). b. Structure of a single monomer. Note that the trench with His154,
the site of cap attachment, is outside the particles, while the C-terminus of Gag, which is
extended as Gag-Pol in one or two subunits per particle, is internal (modified from (Naitow
et al. 2002)).
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Fig. 2.
L-A and M dsRNA cis sites and encoded proteins. a. The L-A genome is shown with the
sites of ribosomal frameshifting, the packaging site (and the overlapping internal replication
enhancer), and the 3' replication site. The His154 cap attachment site is shown as 7mGp.
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Fig. 3.
L-A and M replication cycles.
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Fig. 4.
Schematic diagram of L-A cap-snatching mechanism. Gag of an L-A virion decaps mRNA
and forms an intermediate with m7Gp through His-154. Then m7Gp is transferred to the
diphosphorylated 5’ end of the viral transcript to form a 5’-5’ triphosphate linkage.
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Fig. 5.
20S and 23S RNA viral genomes. A. Total RNA extracted from induced cells containing no
viruses (lane 1), 20S RNA alone (lane 2), or 20S and 23S RNAs (lane 3). Ethidium bromide
staining of an agarose gel is shown. 18S and 25S rRNAs are indicated. B. 20S and 23S RNA
genomes and the encoded proteins, p91 and p104. P91 and p104 contain the consensus
sequences (A-D) for RNA-dependent RNA polymerases, which are most closely related to
those of RNA coliphages. 1-3 indicates amino acid stretches conserved between p91 and
p104. C. Diagram of a launching plasmid. The complete sequence of the 20S or 23S RNA
genome is inserted downstream of the constitutive PGK1 promoter (PGK1). The hepatitis
delta virus ribozyme (R) is fused directly to the 3’ end of the viral genome. Thin lines
indicate sequences derived from the vector.
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Fig. 6.
Cis-acting signals. A. The 3’ terminal sequences of 20S and 23S RNAs with cis-acting
signals. For comparison, the top half domain of tRNATyr is shown. B. The 5’ and 3’
terminal regions of the 20S RNA genome. The 5’ and 3’ cis sites are indicated by lightly
shaded boxes. The initiation (Start) and termination (Stop) codons of p91 are also indicated.
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Fig. 7.
Model for 20S RNA positive strand synthesis. The intermediate may contain two p91
molecules (filled circles). For simplicity, the interaction of p91 with the internal cis site of
the positive strand is omitted.
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Fig. 8.
Yeast prion parallel in-register beta sheet architecture and hypothesized mechanism of
variant information propagation. Parallel in-register beta sheets are characterized by lines of
identical amino acid side chains extending the length of the filaments. These yeast prion beta
sheets are known to be folded along the filament long axis as shown. It is proposed that
different prion variants have the folds in different locations. The parallel structure is
maintained by the favorable interactions of identical side chains. The energetic advantage in
these interactions force a new (unstructured) monomer joining the end of the filament to
become in-register, thereby insuring that the folds/turns of this monomer are in the same
locations as those of previous molecules in the filament. This insures inheritance of prion
variant information (conformation) by templating, analogous to DNA templating of
sequence information.
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Table 1
Amyloid-based yeast prions.
Prion Protein Protein function Phenotype of Prion Ref.
[URE3] Ure2p Negative regulator of catabolism of poor
nitrogen sources
Inappropriate derepression of enzymes and
transporters for poor N sources
(Wickner 1994)
[PSI+] Sup35p Translation termination subunit Inappropriate readthrough of translation
terimination codons
(Wickner 1994)
[PIN+] Rnq1p Unknown Rare priming of other prion formation (Derkatch et al. 2001)
[SWI+] Swi1p Chromatin remodeling complex subunit Poor growth on raffinose, glycerol, or galactose (Du et al. 2008)
[OCT+] Cyc8p Transcription repression factor subunit Defective transcription repression (Patel et al. 2009)
[MOT+] Mot3p Transcription repressor of aerobic-
repressed genes
Inappropriate derepression of ‘anaerobic’ genes (Alberti et al. 2009)
[ISP+] Sfp1p Positive transcription factor of translation-
related genes
Antisuppression (Rogoza et al. 2010)
[MOD+] Mod5p tRNA isopentenyltransferase Partial inactivation of enzyme; (Suzuki et al. 2012)
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